Peripheral blood stem cell transplantation in myeloma using CD34 selected cells

Bone Marrow Transplantation

Volumn 17, Issue 5, 1996, Pages 723-727

  Johnson, R J ^a   Owen, R G ^a   Smith, G M ^a   Child, J A ^a   Galvin, M ^b   Newton, L J ^a   Rawstron, A ^a   Major, K ^a   Woodhead, V ^a   Robinson, F ^a   Jack, A ^a   Morgan, G J ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b PINDERFIELDS GENERAL HOSPITAL   (United Kingdom)

Author keywords

CD34 selection; Myeloma; PBSC

Indexed keywords

ANTINEOPLASTIC AGENT; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; INTERFERON; MELPHALAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; CELL SELECTION; CLINICAL ARTICLE; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MULTIPLE MYELOMA; NEUTROPHIL; PERIPHERAL BLOOD STEM CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELAPSE; REMISSION; STEM CELL TRANSPLANTATION; SURVIVAL; THROMBOCYTE;

ANTIGENS, CD34; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL SEPARATION; CHROMATOGRAPHY, AFFINITY; COMBINED MODALITY THERAPY; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MIDDLE AGED; MULTIPLE MYELOMA; TRANSPLANTATION, AUTOLOGOUS;

EID: 15844375150     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Anderson H, Scarffe JH, Ranson M et al. VAD chemotherapy as remission inducation for multiple myeloma. Br J Cancer 1995; 71: 326-330.
2. Vesole DH, Barlogie B, Jagannath S et al. High-dose therapy for multiple myeloma: improved prognosis with better supportive care and double transplants. Blood 1994; 84: 950-956.
3. Tribalto M, Papa G, Coppetelli U et al. Treatment of multiple myeloma with autologous blood stem cell transplantation. Preliminary results of an Italian multicentric pilot study. Int J Aritific Org 1993; 16 (Suppl. 5): 51-56.
4. Liberti G, Pearce R, Taghipour G et al. Comparison of peripheral blood stem-cell and autologous bone marrow transplantation for lymphoma patients: a case-controlled analysis of the EBMT Registry data. Lymphoma Working Party of the EBMT. Ann Oncol 1994; 5 (Suppl. 2): 151-153.
5. Bird JM, Bloxham D, Samson D et al. Molecular detection of clonally rearranged cells in peripheral blood progenitor cell harvests from multiple myeloma patients. Br J Haematol 1994; 88; 110-116.
6. Owen RG, Haynes AP, Evans PA et al. Detection of clonal immunoglobulin gene rearrangements in the PBSC of patients with multiple myeloma-the potential role of purging with CD34 positive selection. Leukemia (in press).
7. Rhodes EG, Baker PK, Rhodes JM et al. Autologous bone marrow transplantation for myeloma patients using PNA- and CD19-purged marrow rescue. Bone Marrow Transplant 1994; 13: 795-799.
8. + hematopoietic progenitor cells for transplantation. Stem Cells 1993; 11 (SuppL 3): 48-49.
9. + hematopoietic precursors: clinical rationale. Transplant Proc 1992; 24: 3032-3034 (review).
10. Anderson KC, Andersen J, Soiffer R et al. Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma. Blood 1993; 82: 2568-2576.
11. Hardwick A, Law P, Mansour V et al. Development of a large-scale immunomagnetic separation system for harvesting CD34-positive cells from bone marrow. Prog Clin Biol Res 1992; 377: 583-589.
12. Rhodes EG, Baker PK, Duguid JK et al. A method for clinical purging of myeloma bone marrow using peanut agglutinin as an anti-plasma cell agent, in combination with CD 19 monoclonal antibody. Bone Marrow Transplant 1992; 10: 485-489.
13. Sutherland DR, Keating A. The CD34 antigen: structure, biology and potential clinical applications. J Haematother 1992; 1: 115-129 (review).
14. + positive haemopoeitic cells: biology and clinical applications. Blood Rev 1994; 8: 113-124 (review).
15. Vescio RA, Hong CH, Cao J et al. The hematopoietic stem cell antigen, CD34, is not expressed on the malignant cells in multiple myeloma. Blood 1994; 84: 3283-3290.
16. Takishita M, Kosaka M, Goto T, Saito S. Cellular origin and extent of clonal involvement in multiple myeloma: genetic and phenotypic studies. Br J Haematol 1994; 87: 735-742.
17. + marrow cells in patients with breast cancer or neuroblastoma. Blood 1991; 77: 1717-1722.
18. Tricot G, Jagannath S, Vesole D et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood 1995; 85: 588-896 (review).
19. + peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 1995; 86: 390-397.
20. Gordon MY. Plastic-adherent cells in human bone marrow-generate long-term hematopoiesis in vitro. Leukemia 1994; 8: 865-870.
21. Owen RG, Johnson RJ, Evans PA et al. Detection of immunoglobulin gene rearrangements in the PBPC harvests of patients with acute lymphoblastic leukaemia. Bone Marrow Transplant 1995; 16: 831-834.